Federal Register / Vol. 71, No. 164 / Thursday, August 24, 2006 / Notices 50065 

participate, dial 877/315–6535 and enter 

conference code 383520. 

Purpose: Under the charge of the BSC, 

NCEH/ATSDR, the PPRS will provide the 

BSC, NCEH/ATSDR with advice and 

recommendations on NCEH/ATSDR program 

peer review. They will serve the function of 

organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/ 

ATSDR program peer review. 

Matters to be Discussed: A review of the 

minutes from the previous meeting; a 

discussion to finalize members of the Peer 

Review Workgroup for the site specific 

activities’ peer review, external partners and 

customers, and chairperson(s); a discussion 

on the revised schedule for program peer 

reviews; a discussion of Terrorism 

Preparedness and Emergency Response Peer 

Review in February 2007. 

Agenda items are subject to change as 

priorities dictate. 

Supplementary Information: Public 

comment period is scheduled for 11:20–11:30 

a.m. 

For Further Information Contact: Sandra 

Malcom, Committee Management Specialist, 

Office of Science, NCEH/ATSDR, M/S E–28, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333, telephone 404/498–0622. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and NCEH/ATSDR. 

Dated: August 18, 2006. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E6–14032 Filed 8–23–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 71 FR 44298–44300, 

dated August 4, 2006) is amended to 

reflect the transfer of functions and 

name change to Office of Equal 

Employment Opportunity, Office of the 

Director, Centers for Disease Control 

and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Under item (7) of the functional 

statement for the Office of the Chief 

Operating Officer (CAJ), delete the 

following: alternative dispute resolution 

activities. 

Delete in its entirety the title and 

functional statement for the Office of 

Equal Employment Opportunity (CAV), 

and insert the following: 

Office of Dispute Resolution and 

Equal Employment Opportunity (CAV). 

The Office of Dispute Resolution and 

Equal Employment Opportunity 

(ODREEO) is located in the Office of the 

Director, Centers for Disease Control 

and Prevention (CDC). The Director, 

ODREEO, serves as the principal advisor 

to the Director, CDC, on all equal 

employment opportunity matters. The 

ODREEO: (1) Develops and recommends 

for adoption CDC-wide equal 

employment opportunity policies, goals, 

and priorities to carry out the directives 

of the U.S. Office of Personnel 

Management, U.S. Equal Employment 

Opportunity Commission, and 

Department of Health and Human 

Services (DHHS) equal employment 

opportunity policies and requirements 

that are mandated by Title VII, Civil 

Rights Act of 1964; Age Discrimination 

in Employment Act (ADEA); 

Rehabilitation Act of 1973; Civil Service 

Reform Act; 29 CFR 1614, Federal 

Sector Equal Employment Opportunity; 

Executive Order 11478, Equal 

Employment Opportunity in the Federal 

Government; (2) provides leadership, 

direction, and technical guidance to 

CDC managers and staff for the 

development of comprehensive 

programs and plans; (3) coordinates and 

evaluates agency equal employment 

opportunity operations and plans, 

including affirmative action; (4) 

develops plans, programs, and 

procedures to assure the prompt receipt, 

investigation, and resolution of 

complaints of alleged discrimination by 

reason of race, sex, age, religion, 

national origin, handicap, or by reason 

of reprisal or retaliation; (5) coordinates 

the development of comprehensive 

special emphasis programs to assure full 

recognition of the needs of women, 

Hispanics, other minorities and the 

handicapped in hiring and employment; 

(6) identifies needs for ODREEO 

functions within CDC and assures the 

development of a training curriculum 

for all CDC supervisory personnel; (7) 

prepares or coordinates the preparation 

of, reports and analyses designed to 

reflect the status of employment of 

women and minorities at CDC and 

maintains liaison with DHHS and other 

organizations concerned with equal 

employment opportunity; (8) ensures 

effective coordination of ODREEO 

activities with CDC personnel and 

training programs, and with CDC 

national centers manpower planning 

and support programs in the health 

professions; (9) develops a system of 

structured reviews and evaluations of 

CDC ODREEO activities to assure 

effective operations and accountability; 

(10) assists in assuring the adequate 

allocation of resources for ODREEO 

including the establishment of 

guidelines for recruiting, selection, and 

training of agency personnel; (11) 

develops and directs research and 

evaluation studies to focus on, and 

improve the effectiveness of, ODREEO 

program activities; (12) provides 

direction for the agency’s alternative 

dispute resolution activities, and (13) 

provides direct support for ODREEO 

program activities in CDC. 

Dated: August 14, 2006. 

William H. Gimson, 

Chief Operating Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. 06–7117 Filed 8–23–06; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Updated Vaccine Information 

Statements for Influenza Vaccines; 

Revised Instructions for Use of 

Vaccine Information Statements 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: Under the National 

Childhood Vaccine Injury Act (NCVIA) 

(42 U.S.C. 300aa–26), the CDC must 

develop vaccine information materials 

that all health care providers are 

required to give to patients/parents prior 

to administration of specific vaccines. 

Since January 1, 2006, use of trivalent 

influenza vaccine information materials 

has been required. This notice 

announces availability of updated 

influenza vaccine information materials 

for use in the upcoming 2006–07 

influenza season. 

DATES: Each health care provider who 

administers any trivalent influenza 

vaccine to any child or adult in the 

United States during the 2006–07 

influenza season shall provide copies of 

the relevant influenza vaccine 

information materials referenced in this 

notice, dated June 30, 2006, to the 

patient/parent/legal representative in 

conformance with the June 30, 2006 


rmajette on PROD1PC67 with NOTICES1